+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Digital Breast Tomosynthesis (DBT) Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (2D-3D Combination Systems, Standalone 3D Systems), By Component (Hardware, Software, Services), By End-User (Hospitals, Diagnostic Imaging Centers, Breast Cancer Clinics, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Digital Breast Tomosynthesis (DBT) Market size is forecast to increase from $3.84 Billion in 2026 to $10.35 Billion in 2034 at a CAGR of 13.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006817
Pages: 215 Pages

Digital Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Diagnostic Biomarkers, Monitoring Biomarkers, Predictive and Prognostic Biomarkers), By Data Type (Physiological Data, Behavioral Data, Biochemical ), By Technology Platform (Wearable Devices, Mobile Applications, Sensors and Remote Monitoring Devices), By End User (Pharmaceutical and Biotechnology Companies, Healthcare Providers, Research Organizations and CROs, Payers and Insurance Companies) Companies, and Country Forecast, 2021 to 2034

Global Digital Biomarkers Market size is forecast to increase from $8.48 Billion in 2026 to $28.58 Billion in 2034 at a CAGR of 16.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006815
Pages: 225 Pages

Digital Biology Market Size, Share and Growth Outlook, 2026: Analysis By Application (Drug Discovery, Synthetic Biology, Precision Medicine, Clinical Diagnostics, Agricultural Biotechnology), By Component (Solutions, Services), By End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Healthcare Providers, Agricultural Companies) Companies, and Country Forecast, 2021 to 2034

Global Digital Biology Market size is forecast to increase from $22.15 Billion in 2026 to $91.5 Billion in 2034 at a CAGR of 19.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006814
Pages: 212 Pages

Digit Joint Implants Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Hand, Foot, Trapeziometacarpal ), By Material (Titanium and Titanium Alloys, Polymers , Nitinol , Ceramics and Pyrocarbon), By Application (Rheumatoid Arthritis and Osteoarthritis, Trauma and Fracture Repair, Congenital Deformities and Reconstruction), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers , Academic and Research Centers) Companies, and Country Forecast, 2021 to 2034

Global Digit Joint Implants Market size is forecast to increase from $170.77 Million in 2026 to $311.43 Million in 2034 at a CAGR of 7.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006813
Pages: 220 Pages

Digestive Health Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Probiotics, Prebiotics, Digestive Enzymes, Botanicals and Herbal Supplements, Synbiotics and Others), By Form (Capsules and Softgels, Tablets, Gummies and Chewables, Powders, Liquids and Syrups), By Application (General Digestive Support, Gut Microbiome Restoration, Immunity Boosting, Weight Management, Specific Condition Relief ), By Distribution Channel (Retail Pharmacies, Online, Specialty Health Stores, Hypermarkets and Supermarkets) Companies, and Country Forecast, 2021 to 2034

Global Digestive Health Supplements Market size is forecast to increase from $17.76 Billion in 2026 to $37.52 Billion in 2034 at a CAGR of 9.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006812
Pages: 214 Pages

Digestive Enzymes Market Size, Share and Growth Outlook, 2026: Analysis By Enzyme Type (Carbohydrase , Protease, Lipase, Other Enzyme Types), By Source (Microbial-Derived, Plant-Derived, Animal-Derived), By Application (Indigestion and Digestive Disorders, Chronic Pancreatitis, Irritable Bowel Syndrome , Sports Nutrition and Weight Management), By Form (Tablets and Capsules, Powders, Liquids and Sprays, Chewables and Gummies), By Distribution Channel (Pharmacies and Drug Stores, Supermarkets and Hypermarkets, Online, Health and Wellness Stores) Companies, and Country Forecast, 2021 to 2034

Global Digestive Enzymes Market size is forecast to increase from $1.41 Billion in 2026 to $2.79 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006811
Pages: 225 Pages

Digestive Enzyme Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Product Type: (Lipase, Protease, Amylase, Lactase, Cellulase, Multi-Enzyme Blends), By Source: (Animal-based, Plant-based, Microbial-based), By Formulation: (Capsules, Tablets, Powders, Chewables), By End-User: (Adults, Pediatrics, Geriatrics), By Distribution Channel: (Pharmacies & Drug Stores, Health & Beauty Retailers, Online Channels) Companies, and Country Forecast, 2021 to 2034

Global Digestive Enzyme Supplements Market size is forecast to increase from $1.81 Billion in 2026 to $3 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006810
Pages: 225 Pages

Digestive and Intestinal Remedies Market Size, Share and Growth Outlook, 2026: Analysis By Product Type: (Antacids, Laxatives, Antidiarrheal Agents, Antispasmodics, Proton Pump Inhibitors , H2 Blockers), By Formulation: (Tablets, Capsules, Liquids, Powders, Gels), By Distribution Channel: (Retail Pharmacies, Hospital Pharmacies, E-commerce, Supermarkets), By End-User: (Hospitals, Clinics, Home-care) Companies, and Country Forecast, 2021 to 2034

Global Digestive and Intestinal Remedies Market size is forecast to increase from $30.72 Billion in 2026 to $50.46 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006809
Pages: 219 Pages

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type: (Chemotherapy, Immunotherapy, Targeted Therapy, Cell Therapy , Stem Cell Transplantation), By Drug Class: (Monoclonal Antibodies, ADCs , Bispecific Antibodies, Kinase Inhibitors), By Distribution Channel: (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies), By End-User: (Hospitals, Cancer Research Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is forecast to increase from $4.59 Billion in 2026 to $7.77 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006808
Pages: 212 Pages